There are also known pathophysiologic pathways for obesity with, for example, poor sleep through decreased leptin, increased ghrelin, and other mediators (glucagon-like peptide-1 and peptide YY) [4, 45, 46]. This evidence concerns the gene LEP and obesity disorder.